UBX-106 / Ubix Therap, SK Bio - LARVOL DELTA

Ubix Therapeutics Accepted into Johnson & Johnson Innovation – JLABS (Ubix Therap Press Release) - "Ubix Therapeutics, Inc...announced today its acceptance as a member of the Johnson & Johnson Innovation – JLABS (JLABS) Korea community....'We plan to leverage the membership to further advance our pipeline, including UBX-106, a SHP2 degrader program set to enter IND-enabling studies, and to strengthen our efforts in building global partnerships'."

Commercial • Oncology